Clinical trials recruiting for Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Leronlimab (700mg) | 1 |
| Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Maryland | 1 |
| Massachusetts | 1 |
| New York | 1 |
| Texas | 1 |
Top cities
Self-screener
Recruiting trials
- Infrared Light for Memory Loss in Mild Cognitive Impairment (MCI)
- Longitudinal Profiling of Plasma-Derived Glial Extracellular Vesicles in Alzheimer's Disease
- Medicare Anti-Aβ mAb Coverage With Evidence Development (CED) Study
- Mindfulness for Cognition in Early-stage Alzheimer's Disease
- NON-INVASIVE BRAIN STIMULATION FOR MEMORY LOSS IN EARLY ALZHEIMER'S DISEASE
- Safety Assessment of Leronlimab and Its Effect on Brain Inflammation in Alzheimer's Disease
- The Role of METhanogens in the PROgression Of Parkinson's Disease and Related Neurological Conditions
Related conditions
Trials recruiting for Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.